ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

ASCO Teleconference Set For Nov. 12

October 31, 1986

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996

Tri-Institutional Stem Cell Initiative Funds Grants.

August 4, 2006

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979